COMPASS PATHWAYS PLC Increase (Decrease) in Prepaid Expenses, Other
COMPASS PATHWAYS PLC (CMPS) reported Increase (Decrease) in Prepaid Expenses, Other of $6.80 million for the 9-month period ending 2021-09-30, per its 6-K filed 2021-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2021-11-09
- COMPASS PATHWAYS PLC increase (decrease) in prepaid expenses, other for the quarter ending 2021-09-30 was $1.43M, a 46.11% decline year-over-year.
- COMPASS PATHWAYS PLC increase (decrease) in prepaid expenses, other for the quarter ending 2020-09-30 was $2.66M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month |
|---|---|---|---|
| 2021-09-30 | $1.43M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $6.80M 6-K · filed 2021-11-09 | |
| 2021-06-30 | $5.37M 6-K · filed 2021-08-11 | ||
| 2020-09-30 | $2.66M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $3.69M 6-K · filed 2021-11-09 | |
| 2020-06-30 | $1.03M 6-K · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |